Oct
2026
Fiera Milano, Italy
Visit us
stand 14G9, Finished Dosage & Formulation
Invex Health Pvt. Ltd.
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:India
-
On CPHI since:2022
-
Certificates:4
-
Employees:25 - 49
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 14G9, Finished Dosage & Formulation
Products Featured at CPHI Milan 2026
-
Product Biosimilars
Products: Trastuzumab Bevacizumab Rituximab Adalimumab Etanercept Tenecteplase Plant Approval: EUGMP, WHO GMP, Philippines FDA & TMMDA -
Product Blood Products
Products: Human Albumin IVIG Dried Factor VIII Fraction Erythropoietin Darbepoetin alfa Injection Filgrastim Human Anti-D Immunoglobulin Plant Approval: WHOGMP, Kenya, Ethiopia -
Product Tinefcon
A patented & clinically proven product for management of psoriasis, backed up with years of extensive R&D and clinical trials1. Tinefcon is the WORLD’s first ORAL TNF- Alpha down regulator
2. Tinefcon presents the only holistic approach for the&nb... -
Product Peg-asparaginase & other oncology products
• Vandetanib tablets • L - Asparaginase injection • Peg - Asparaginase injection • Thiotepa injection • Melphalan injection • Paclitaxel Albumin bound nanoparticle injection • Plerixafor injection and more... -
Product Bevacizumab & other Biosimilars
• Trastuzumab • Rituximab • Adalimumab • Etanercept • Tenecteplase & More
Invex Health Resources (1)
-
Brochure Product list (ROW market)
These are the products available for ROW markets with dossier status.




